Anne Nikkonen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anne Nikkonen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anne Salonen
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
1 shared publication - Kaija-Leena Kolho
New Children's Hospital, Pediatric Research Center Helsinki University Hospital HUS and Faculty of Medicine, University of Helsinki Helsinki Finland
1 shared publication - Katri Korpela
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
1 shared publication - Rebecka Ventin-Holmberg
Folkhälsan Research Center, Biomedicum, Helsinki, Finland; Immunomics Research Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland
1 shared publication - Schahzad Saqib
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki , Haartmaninkatu 8, P.O. Box 63, 00014, Helsinki
1 shared publication - Ville Peltola
Department of Paediatrics and Adolescent Medicine Turku University Hospital and University of Turku Turku Finland
1 shared publication
Latest Publications
- Open Access
- 22 March 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (4) , 328
The Effect of Antibiotics on the Infant Gut Fungal Microbiota
Antibiotics are commonly used drugs in infants, causing disruptions in the developing gut microbiota with possible detrimental long-term effects such as chronic inflammatory diseases. The focus has been on bacteria, but research shows that fungi might have an important role as well. There are only a few studies on the infant gut fungal microbiota, the mycobiota, in relation to antibiotic treatment. Here, the aim was to investigate the impact of antibiotics on the infant gut mycobiota, and the interkingdom associations between bacteria and fungi. We had 37 antibiotic-naïve patients suffering from respiratory syncytial virus, of which 21 received one to four courses of antibiotics due to complications, and 16 remained antibiotic-naïve throughout the study. Fecal samples were collected before, during and after antibiotic treatment with a follow-up period of up to 9.5 months. The gut mycobiota was studied by Illumina MiSeq sequencing of the ITS1 region. We found that antibiotic use affected the gut mycobiota, most prominently seen as a higher relative abundance of Candida (p < 0.001), and a higher fungal diversity (p = 0.005–0.04) and richness (p = 0.03) in the antibiotic-treated infants compared to the antibiotic-naïve ones at multiple timepoints. This indicates that the gut mycobiota could contribute to the long-term consequences of antibiotic treatments.
- 22 March 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (4) , 328
Open AccessThe Effect of Antibiotics on the Infant Gut Fungal Microbiota
Antibiotics are commonly used drugs in infants, causing disruptions in the developing gut microbiota with possible detrimental long-term effects such as chronic inflammatory diseases. The focus has been on bacteria, but research shows that fungi might have an important role as well. There are only a few studies on the infant gut fungal microbiota, the mycobiota, in relation to antibiotic treatment. Here, the aim was to investigate the impact of antibiotics on the infant gut mycobiota, and the interkingdom associations between bacteria and fungi. We had 37 antibiotic-naïve patients suffering from respiratory syncytial virus, of which 21 received one to four courses of antibiotics due to complications, and 16 remained antibiotic-naïve throughout the study. Fecal samples were collected before, during and after antibiotic treatment with a follow-up period of up to 9.5 months. The gut mycobiota was studied by Illumina MiSeq sequencing of the ITS1 region. We found that antibiotic use affected the gut mycobiota, most prominently seen as a higher relative abundance of Candida (p < 0.001), and a higher fungal diversity (p = 0.005–0.04) and richness (p = 0.03) in the antibiotic-treated infants compared to the antibiotic-naïve ones at multiple timepoints. This indicates that the gut mycobiota could contribute to the long-term consequences of antibiotic treatments.